Clinical trial
Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia…
NCT00442130 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00442130 |
|---|---|
| Title | Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination |
| Official title | Reduced Intensity Stem Cell Transplantation for Advanced Chronic Lymphocytic Leukemia Followed by Vaccination With Lethally Irradiated Autologous Tumor Cells Admixed With Granulocyte Macrophage-colony Stimulating Factor Secreting K562 Cells |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Chronic Lymphocytic Leukemia |
| Intervention type | Biological, Procedure |
| Interventions | GM-K562 vaccine, stem cell transplantation |
| Enrollment | 27 |
| Start date | Feb 1, 2007 |
| Primary completion | Feb 1, 2014 |
| Completion | Apr 1, 2020 |
| First posted | Mar 1, 2007 |
| Last update posted | Sep 17, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: